|
HS Code |
464006 |
| Productname | 3-Bromo-[1,2,4]Thiazo[4,3-A]Pyridine |
| Molecularformula | C6H3BrN2S |
| Molecularweight | 215.08 g/mol |
| Casnumber | 170643-02-4 |
| Appearance | Off-white to light yellow solid |
| Solubility | Soluble in DMSO, DMF; partially soluble in water |
| Smiles | Brc1ncc2nsnc2c1 |
| Inchi | InChI=1S/C6H3BrN2S/c7-4-2-8-3-5-6(4)10-1-9-5/h2-3H,1H2 |
| Pubchemcid | 13169361 |
As an accredited 3-Bromo-[1,2,4]Thiazo[4,3-A]Pyridine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 3-Bromo-[1,2,4]Thiazo[4,3-A]Pyridine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
In today's laboratories and research facilities, chemists often hunt for uncommon reagents—building blocks that shift the landscape of synthetic capability. One compound, 3-Bromo-[1,2,4]Thiazo[4,3-A]Pyridine, pops up as more than a curiosity; it supports the development of new functionalized molecules, key drugs, and specialized materials. My own time juggling reactions with heterocyclic bromides taught me their influence isn't pure theory. Seemingly small structural changes can spiral into radical functional differences in pharmacology, catalysis, or materials science. Walking through shelves lined with common halides and the usual ring systems, this one stands out because of its hybrid structure merging the thiazole and pyridine frameworks—a marriage that stirs up interesting reactivity and selectivity.
The interest stems not just from its name, but from real-world capability. Chemists keep circling back to scaffolds featuring both nitrogen and sulfur, as they can draw electrons and donate them in ways carbon-skeletons can't. Add a bromine atom to the mix, and possibilities open up—couplings, substitutions, and more. The 3-bromo substituent lands precisely on a structure that gives rise to both biological and industrial relevance. The thiazolopyridine ring system has shown up in kinase inhibitors and antimicrobial candidates, which gets any medicinal chemist’s attention. I’ve often seen a jump in reactivity or selectivity when switching from carbon- or nitrogen-only heterocycles to those bearing sulfur. The unique electronics change hydrogen bonding and stacking interactions, creating activity where analogs show none.
The demand for this compound doesn't come out of nowhere. Chemically, 3-Bromo-[1,2,4]Thiazo[4,3-A]Pyridine packs a punch. It is not the run-of-the-mill bromoheterocycle seen in basic classrooms or general catalogs. Integration of the 1,2,4-thiazole ring fused to pyridine is what stirs up innovation. At a molecular weight that sits in a comfortable mid-range for benchwork, researchers—especially those focused on scalable synthesis—can use it in manageable quantities without bumping into problematic volatility or extreme reactivity. Bromine is often prized for its stability and useful leaving-group properties, which makes this molecule particularly friendly to Suzuki, Sonogashira, and Buchwald–Hartwig reactions.
In my experience, handling this molecule is a world apart from broader, simpler halopyridines or thiazoles. It flows as a crystalline solid with stability at room temperature, so it doesn’t have the nasty volatility or rapid darkening some sulfur analogs show. This gives it staying power in storage, thus reducing waste in the lab. Accurate weighing keeps projects reproducible—something rarely discussed, but anyone who has lost material from volatilization understands the frustration. Purity standards typically hit above 98 percent for research-grade samples, which matters if you want cleaner reaction profiles and less troubleshooting downstream.
What excites me most is where synthetic chemists utilize this compound. Installing the 3-bromo handle on a complex fused ring system transforms its fate. In C–C or C–N bond formations, this structure serves as a springboard for complex molecule assembly. The thiazolopyridine scaffold has deep roots in pharmaceutical discovery—lead structures that morph into candidates for inflammation, infection, or cancer therapies. A researcher might start with a simple halogenated core and gradually layer on complexity, building libraries of compounds around a robust, versatile nucleus.
Thiazolopyridines have surfaced in patents around kinase inhibition, anti-parasitic agents, and agrochemical leads. Drawing from episodes in medicinal chemistry projects, using a rare fused heterocycle often carves out patentable space—essential for companies wary of crowded intellectual property landscapes. Adding a bromine at the 3-position creates a handle for diversification, especially with modern cross-coupling reactions streamlining the process. Additionally, the structure brings aromaticity and planarity, making it a welcomed guest for π-stacking interactions or docking into enzyme active sites.
Practical uses stretch into material science, too. Heteroaromatic structures built from sulfur and nitrogen often display unique optical or electronic properties. Adding a bromine allows further elaboration, leading to molecules that absorb at interesting wavelengths or facilitate charge transport. Laboratories working on organic electronics or new dyes keep their eyes on such building blocks, constantly screening for new candidates.
One might ask what truly separates this compound from heavier-hitting halogenated heterocycles, such as 3-chloro analogs or even related thiazolopyridine isomers. In practice, substitution patterns dictate electronic push and pull, reactivity, and downstream compatibility. Bromine, thanks to its size and electron-withdrawing properties, sits in a goldilocks space for subsequent functionalization—more reactive than its chloro cousins but without the sometimes too-hot touch of iodine. The 3-position on this scaffold, subtly shielded and activated by neighboring atoms, behaves differently from unconstrained bromopyridines or bromo-thiazoles. I’ve run cross-coupling screens where switching from a more common bromo substrate to this compound dramatically increased yield and purity, probably because of the fused-ring rigidity.
Those working with other thiazolopyridine isomers will notice distinct reactivity trends when shifting the bromine to alternate positions, but the 3-bromo variant often stands out in coupling reactions, thanks to improved regioselectivity. In my own hands, it produced fewer byproducts and better reproducibility—a welcome change for both academic pursuits and pilot-scale experiments.
It’s easy to overlook the value of careful data and repeated trials—but trust in a compound’s consistency and its characterization data underpins progress. The most reputable labs provide robust NMR, MS, and elemental results. Comprehensive documentation ensures chemists aren’t left guessing about identity or purity. That matters when synthesizing valuable analogs or working within tight regulatory frameworks, such as drug lead optimization or fine chemical manufacturing. In my years working with high-value building blocks, only those coupled with transparent, reproducible specifications became mainstays in my workflow.
The thiazolopyridine family—especially bromo derivatives—draws repeat buyers in industrial settings for this reason. Reliability over long runs and between batches supports scale-up without time lost troubleshooting. That reliability builds credibility with regulatory teams and investors, fueling further application in critical sectors from pharmaceuticals to specialty polymers.
No compound breezes through every application without hurdles. 3-Bromo-[1,2,4]Thiazo[4,3-A]Pyridine holds up to plenty of reactions, but care in handling and risk management matters, especially at larger scales. Sulfur- and bromine-containing aromatics sometimes stir up concerns around occupational safety and environmental stewardship. Bringing my own lessons to the table, gloves, optimized ventilation, and containment strategies keep exposure risks low. Waste protocols stand as important as bench chemistry—responsible handling of halogenated and sulfur-containing residues means following local environmental guidelines.
Practical solutions often start at the bench: running small-scale reactions to establish ideal conditions before scaling up saves both materials and time. Careful monitoring with thin-layer or column chromatography picks up on residual starting material—critical, since halogenated heterocycles at high purities demand diligent purification. Relying on trusted vendors or in-house quality control helps keep standards from slipping, making life easier when reactions run days at a time.
From a broader vantage point, increased access to optimized synthetic routes—often published openly or shared among collaborating labs—lets less-experienced researchers build confidence and cut down on trial-and-error. Techniques like microwave-assisted couplings, which I’ve used frequently, shrink reaction times and boost yields with this particular scaffold, minimizing exposure to reagents and reducing solvent waste. This sort of process intensification matches the needs of modern sustainable chemistry, pairing efficient use of resources with robust safety profiles.
Availability shapes the story of a chemical’s success almost as much as its reactivity. Bottlenecks can appear suddenly—tight raw material supplies, transportation delays, or inconsistent demand cycles. As witnessed in recent years with other specialty reagents, small disruptions impact deliverables and slow innovation. Reliable sources with transparent chain-of-custody practices take on growing importance, making this aspect a shared priority for research and industry. I’ve encountered situations where projects paused for weeks, just waiting on backordered starting materials; such delays ripple through entire organizations.
Solutions to these supply challenges emerge from diversification of suppliers, regular reviews of quality control metrics, and advance purchasing for high-traffic projects. Strong communication—both upstream from vendors and downstream to research teams—avoids costly surprises. Some groups now explore on-demand synthesis models, with modular precursors assembled just before use. While these don’t fit every scenario, they foster resilience and can smooth supply bumps.
Researchers across chemistry, biology, materials science, and even engineering can benefit from folding this compound into their experimental toolkits. It opens up strategies for constructing molecules with properties not found in traditional ring systems. Cross-disciplinary collaboration shines here: those working in computational drug design, for instance, gain a fresh scaffold to dock in virtual libraries; wet-lab teams then chase the most promising hits.
Having worked on both sides—modeling binding pockets at a desk, then slamming together molecules at a bench—I have seen firsthand how a distinctive building block can jolt a project forward. Sometimes it’s the subtle difference in ring electronics or the geometry of the fused system that nudges a molecule into greater bioactivity or makes a better fit in polymer matrices. There’s a reason thiazolopyridines keep resurfacing in published patents and new product announcements: they fill gaps left by older chemical libraries.
3-Bromo-[1,2,4]Thiazo[4,3-A]Pyridine lends itself to targeted modification, so iterative analog synthesis becomes possible with fewer synthetic steps. This supports both hit-to-lead campaigns and broader library generation. For medicinal chemists, every extra analog means a better shot at efficacy with lower off-target effects. For material scientists, such structures might mean improved charge mobility or new luminescent behavior—features that play out over and over in journal articles and tech disclosures.
The pace of innovation sometimes brings new molecules faster than regulatory and ethical frameworks can keep up. Researchers, suppliers, and end users all play a part in ensuring that novel building blocks like 3-Bromo-[1,2,4]Thiazo[4,3-A]Pyridine are used wisely, safely, and with an eye on long-term consequences. Sharing best practices—either through formal safety protocols or informal discussions at conferences—helps close gaps in knowledge, especially for emerging chemists.
Trust in supply chains, careful stewardship in using and disposing of chemicals, and a continuous focus on sustainability shape today’s priorities. The global shift towards green chemistry principles encourages us all to rethink solvents, energy use, and end-of-life disposal for specialty reagents. Documenting and sharing improved methods, both within academic papers and industry case studies, pushes the field forward without unnecessary duplication of effort. In my work, I’ve benefited tremendously from open dialogues with peers, workshops, and even online forums dedicated to synthetic hurdles and safety updates.
What stands out about 3-Bromo-[1,2,4]Thiazo[4,3-A]Pyridine goes beyond its structure or immediate reactivity. It’s a touchstone for creativity, allowing chemists to tinker with unique frameworks and build structures with fine-tuned properties. It reflects a balance between established synthetic wisdom and the drive to explore uncharted territory.
For years, I’ve seen compounds like this quietly transform work at the bench. Laboring over reaction optimization, even minor tweaks in halogen placement made all the difference in yield, purity, and downstream modification. Sulfur-nitrogen fused rings have challenged and rewarded determination, providing both headaches and triumphs. Using a high-purity sample saves time on chromatography and trouble with analytical data. Partnering with trusted suppliers gave peace of mind—a bad batch leads to redoing entire campaigns.
I recall a project aiming to build a kinase inhibitor library, hunting for selectivity against a tricky protein target. Swapping in 3-Bromo-[1,2,4]Thiazo[4,3-A]Pyridine brought a jump in inhibitory potency, something not seen with simpler bromopyridines or chloro analogs. The fused structure presented new binding surfaces and different hydrogen-bonding patterns. Wet-lab results matched docking predictions, affirming that this wasn’t just a theoretical curiosity. Colleagues in adjacent labs crossed over, wanting access to the same core for their own structure-activity relationship projects.
On the analytical side, purity checks delivered consistent results—no lingering spots on TLC that signal trouble during scale-up. Mass spec and NMR profiles cleanly matched expectations from the literature. This level of certainty gives a lab confidence both in the moment and years later, when someone pulls results for patent filing or regulatory review.
Adopting newer synthetic techniques has turbocharged the application of such nonstandard heterocycles. Techniques like flow chemistry, continuous processing, and high-throughput screening now give more people access to these molecules than ever before. These methods slash reaction times, reduce waste, and open possibilities for parallel experimentation. The fusion of old wisdom and new tech keeps complex halogenated scaffolds like this on the leading edge.
Teaching new researchers in the lab about these workflows—emphasizing careful ligand choice, gentle heat, and patience over brute-force conditions—unlocks better yields and less frustration. Documenting both successes and failures, storing spectra and chromatograms on shared databases, and publishing detailed methods helps the next generation climb the learning curve with fewer missteps.
3-Bromo-[1,2,4]Thiazo[4,3-A]Pyridine draws from decades of research while feeding into the forefront of scientific inquiry. Its structure embodies the blending of tradition with progress, providing a gateway to new drugs, advanced materials, and imaginative molecular architectures. The lessons learned from working with it—patience, meticulous documentation, attention to detail—mirror the qualities that define the best in chemistry, whether in an academic basement lab or a cutting-edge pharma facility.
The compound not only delivers reactivity on demand but also brings a story of careful advancement—measured, supported by data, open for dialogue, and always in pursuit of something new. In my experience, and across the chemical community, it stands as a testament to the enduring value of innovation married to responsibility.